Evidence-informed information for prospective patients considering TRT for men or regulated body-identical hormone therapy for women

Prepared for patient education and informed discussion with a clinician

Contents

• Welcome: How to use this guide - Why this pack exists and what it can and cannot tell you.
• Part I - Men: Testosterone Replacement Therapy - Symptoms, testing, treatment expectations, monitoring, fertility, prostate and cardiovascular safety.
• Part II - Women: Regulated body-identical menopause hormone therapy - Estradiol, micronised progesterone, symptoms, breast/cardiovascular risk, bone, sleep and compounded therapy.
• Evidence reading entries - Patient-focused explanations of 16 men/TRT articles and 18 women/MHT articles, with full-text source links.
• Questions to bring to your consultation - Practical prompts for a safer and more useful clinical discussion.

Welcome: How to Use This Guide

Many people arrive at hormone care after months or years of symptoms that have affected energy, mood, sleep, confidence, sex life, weight, strength, mental clarity, or general quality of life. This guide is written for prospective patients who want to understand the science without needing to read dozens of full academic papers before their first consultation.

The guide translates the scientific reading pack into plain, patient-facing language. It explains what the research may mean, what it does not prove, and which questions are worth discussing with a clinician. It is intentionally careful: hormone treatment can be life-changing for some patients, inappropriate for others, and unsafe if used without proper diagnosis and monitoring.

Part I - Men: Testosterone Replacement Therapy

Testosterone replacement therapy, often called TRT, is a medical treatment for men who have both compatible symptoms and persistently low testosterone confirmed by blood testing. The aim is not to create a super-normal hormone level. The aim is to restore testosterone toward a physiological range when there is a genuine deficiency and when treatment is appropriate for the patient’s overall health.

Symptoms that may lead a man to ask about testosterone

• Reduced libido or fewer morning erections
• Erectile difficulties, especially when combined with reduced sexual desire
• Persistent fatigue, loss of drive, reduced motivation or reduced wellbeing
• Loss of muscle, increased abdominal fat, poorer exercise recovery or reduced strength
• Low mood, irritability, brain fog or reduced confidence
• Low bone density, unexplained anaemia, or metabolic problems where testosterone deficiency is suspected

These symptoms are not specific to testosterone deficiency. They can also be caused by poor sleep, sleep apnoea, stress, depression, thyroid disease, diabetes, obesity, alcohol, medications, relationship strain, overtraining, under-eating, or other medical conditions. This is why proper diagnosis matters.

What a responsible TRT assessment usually considers

• Repeated morning testosterone blood tests, interpreted with free testosterone or SHBG when appropriate.
• LH, FSH and prolactin to help distinguish primary from secondary hypogonadism.
• Full blood count, especially haematocrit, because TRT can increase red blood cell production.
• PSA and prostate history where clinically appropriate.
• Blood pressure, cholesterol, glucose/diabetes risk, weight, sleep apnoea risk and cardiovascular history.
• Fertility intentions, because standard TRT can reduce sperm production.

Patient-Friendly Evidence Entries: Men and TRT

1. Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men

Why this matters for you

This large real-world study is useful because it reflects men being treated in routine clinical practice, not only in tightly controlled trials.

What the research suggests in patient language

• TRT is usually considered only when symptoms fit and blood tests repeatedly show low testosterone.
• Many men seek help because of low energy, reduced libido, loss of drive, poorer recovery, mood change, or changes in body composition, but these symptoms can have other causes too.
• The study supports a monitored approach: treatment should be reviewed using symptoms, testosterone levels, blood count, prostate markers where appropriate, and side-effect checks.

What this does not mean

A large cohort does not prove that every symptom will improve for every man. It helps show patterns and safety signals, but your own medical history still matters.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

2. Oncological Safety of Testosterone Replacement Therapy in Patients With Prostate Cancer: A Systematic Review

Why this matters for you

This review looks at a sensitive question: whether testosterone therapy can ever be considered in men with a history of prostate cancer.

What the research suggests in patient language

• Older thinking treated testosterone and prostate cancer as a simple one-way danger, but modern evidence is more nuanced.
• Some carefully selected men after successful prostate cancer treatment may be assessed for TRT, usually with specialist input.
• Active, untreated, advanced, or high-risk prostate cancer is a very different situation and requires specialist judgement.

What this does not mean

This does not mean TRT is automatically safe after prostate cancer. It means the decision must be individualised, cautious, documented, and closely monitored.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

3. Testosterone Replacement Therapy as a Potential Strategy to Counteract Age-Related Decline of Skeletal Muscle

Why this matters for you

This article is relevant for men who notice declining strength, increasing abdominal fat, poorer recovery, or loss of muscle with age.

What the research suggests in patient language

• Low testosterone can contribute to reduced lean mass and poorer physical function in some men.
• TRT may help restore physiology in genuinely deficient men, but it is not a replacement for resistance training, sleep, protein intake, or weight management.
• Muscle and body-composition changes are usually gradual and should be assessed alongside overall health.

What this does not mean

TRT should not be presented as bodybuilding treatment or a shortcut to athletic performance. The medical aim is restoration, not enhancement beyond normal physiology.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

4. Psychiatric and Cognitive Effects of Testosterone Therapy in Adult Men With Testosterone Deficiency: A Systematic Review

Why this matters for you

This review is helpful for patients who wonder whether low testosterone could be linked with mood, motivation, irritability, confidence, or concentration.

What the research suggests in patient language

• Low testosterone can overlap with low mood, fatigue, poor concentration, and reduced wellbeing.
• Some men may experience improvements in wellbeing when true deficiency is corrected.
• Depression, anxiety, sleep problems, alcohol use, medication side effects, and stress can produce similar symptoms and should not be ignored.

What this does not mean

TRT is not a primary treatment for mental illness. Severe depression, suicidal thoughts, or major anxiety symptoms require appropriate medical and psychological care.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

5. Testosterone Replacement Therapy in Athletes

Why this matters for you

This article is useful because it separates medically indicated TRT from performance-enhancing steroid use.

What the research suggests in patient language

• TRT for a patient with confirmed testosterone deficiency is different from supraphysiological anabolic steroid use.
• A responsible clinic should not treat TRT as a way to gain an unfair sporting advantage or push testosterone above physiological levels.
• Athletes may need to consider sport rules, therapeutic-use exemptions, and documentation.

What this does not mean

A medical diagnosis is essential. Wanting more gym progress, more aggression, or faster muscle gain is not the same as needing TRT.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

6. Sleep Apnea, Heart Health and Testosterone

Why this matters for you

This article matters because sleep apnoea can mimic or worsen symptoms often blamed on low testosterone.

What the research suggests in patient language

• Snoring, witnessed pauses in breathing, morning headaches, and daytime sleepiness can point to sleep apnoea.
• Poor sleep can lower testosterone and cause fatigue, low libido, weight gain, and poor concentration.
• Untreated severe sleep apnoea may make TRT riskier and should be assessed before treatment.

What this does not mean

If fatigue is mainly caused by sleep apnoea, TRT alone is unlikely to solve the problem. Treating sleep may be the most important step.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

7. Secondary Hypogonadism and Effects of Testosterone Replacement Therapy

Why this matters for you

This article explains why low testosterone is not one single condition and why the cause matters.

What the research suggests in patient language

• Secondary hypogonadism means the testicles may be capable of producing testosterone, but the brain-pituitary signal is reduced.
• Possible causes include obesity, medication effects, pituitary disease, high prolactin, systemic illness, or previous anabolic steroid use.
• LH, FSH, prolactin, SHBG, thyroid markers and other tests may be needed to understand the cause.

What this does not mean

Starting TRT without understanding the reason for low testosterone can miss important diagnoses and may affect fertility.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

8. Testosterone Replacement Therapy in Hypogonadal Men with Prostate Cancer: A Comprehensive Review of Safety and Efficacy

Why this matters for you

This review offers a broader view of TRT in men with low testosterone and a prostate cancer history.

What the research suggests in patient language

• The question is no longer treated as completely black-and-white in every case.
• The safest pathway is careful selection, shared decision-making, baseline PSA assessment where appropriate, and follow-up monitoring.
• Men with complex prostate cancer histories should expect coordination with a urologist or oncologist.

What this does not mean

This evidence should not be used to self-clear treatment. Prostate cancer history always requires a personalised risk review.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

9. Cardiovascular Effects of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review of Lipid Profiles, Inflammatory Markers, and Endothelial Function

Why this matters for you

This review is relevant for patients concerned about cholesterol, inflammation, blood vessels and heart risk.

What the research suggests in patient language

• Low testosterone is often seen alongside obesity, insulin resistance, type 2 diabetes, and cardiovascular risk factors.
• TRT can influence blood markers, but heart risk is determined by many factors, not testosterone alone.
• A responsible treatment plan should include blood pressure, lipids, diabetes risk, weight, smoking status, family history, and exercise habits.

What this does not mean

TRT is not a stand-alone heart-health treatment. Cardiovascular risk management still depends on lifestyle, medical treatment, and regular monitoring.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

10. Cardiovascular Safety of Testosterone Therapy - Insights from TRAVERSE

Why this matters for you

TRAVERSE-related evidence is important because cardiovascular safety has been one of the biggest questions in TRT.

What the research suggests in patient language

• Large cardiovascular-outcome data have helped clarify risk in appropriately selected men.
• The key lesson for patients is not that monitoring is unnecessary, but that proper selection and follow-up matter.
• Men with recent heart attack, stroke, unstable heart disease, uncontrolled blood pressure or major clotting concerns need careful clinician review.

What this does not mean

No study removes the need for individual risk assessment. Your personal heart history may change whether treatment is appropriate.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

11. Testosterone Therapy in Older Men: Present and Future Perspectives

Why this matters for you

This article is useful for older men who wonder whether declining testosterone is simply ageing or a treatable deficiency.

What the research suggests in patient language

• Testosterone tends to decline with age, but age alone does not automatically mean a man should receive TRT.
• The decision depends on symptoms, repeated morning blood tests, free testosterone interpretation, comorbidities, and treatment goals.
• Older men may need especially careful monitoring for blood count, prostate markers, fluid retention, sleep apnoea and cardiovascular risk.

What this does not mean

TRT should not be sold as anti-ageing medicine. The question is whether a specific man has clinically meaningful testosterone deficiency.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

12. Testosterone Therapy in Men in Their 40s: A Narrative Review of Clinical Management

Why this matters for you

This article is relevant because many men seek help in their 40s when work pressure, family life, weight gain, stress and sleep issues overlap with hormone symptoms.

What the research suggests in patient language

• Symptoms in midlife are often multi-factorial; low testosterone may be part of the picture but not the whole picture.
• Assessment should include fertility plans, lifestyle, medication, alcohol, sleep, mental health, and metabolic risk.
• For some men, weight loss, sleep treatment, or medication changes may improve testosterone without immediate TRT.

What this does not mean

Feeling tired or less motivated in your 40s does not automatically mean TRT is needed. Diagnosis requires clinical and biochemical evidence.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

13. Impact of Testosterone on Male Health: A Systematic Review

Why this matters for you

This broad review helps patients understand testosterone as part of whole-person health, not only sexual function.

What the research suggests in patient language

• Testosterone is linked with libido, erections, mood, energy, red blood cell production, bone, muscle, and metabolic health.
• Symptoms should be interpreted as a pattern, not as a single isolated complaint.
• A good consultation should explore the whole patient, including sleep, weight, medication, alcohol, stress, fertility and cardiovascular risk.

What this does not mean

Because testosterone affects many systems, treatment must be monitored. More is not automatically better.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

14. A Comparative Review of Jatenzo, Tlando, and Kyzatrex

Why this matters for you

This article compares oral testosterone undecanoate products and is useful for understanding that TRT comes in different formulations.

What the research suggests in patient language

• TRT may be delivered by gels, injections, oral preparations, patches or other routes depending on country, licensing and clinical suitability.
• Different routes have different pros and cons: convenience, stability of levels, skin transfer risk, injection peaks, blood pressure considerations and cost.
• Choice of formulation should be individualised rather than based on marketing claims.

What this does not mean

A formulation that is convenient for one patient may not be suitable for another. Monitoring requirements may differ by route.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

15. Preserving Spermatogenesis in Testosterone Deficiency

Why this matters for you

This article is critical for men who may want children now or in the future.

What the research suggests in patient language

• Standard TRT can reduce sperm production because external testosterone can switch off the brain signals that stimulate the testicles.
• Men who want fertility should discuss this before starting treatment.
• Alternative or adjunctive approaches may be considered by clinicians in selected cases, depending on diagnosis and local practice.

What this does not mean

Do not start TRT if you are actively trying to conceive without a fertility discussion. Stopping TRT later may not restore fertility immediately.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

16. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism

Why this matters for you

This study is important because testosterone can influence red blood cell production.

What the research suggests in patient language

• Some testosterone-deficient men with anaemia may see improvement when deficiency is corrected.
• The same mechanism means TRT can sometimes raise haematocrit too much, increasing the need for blood-count monitoring.
• Blood count testing is not optional; it is central to safe TRT.

What this does not mean

Improving anaemia does not mean every patient should have higher red-cell levels. Too high a haematocrit may require dose adjustment, pausing therapy, or further medical management.

Questions to discuss with your clinician

• Do my symptoms and blood tests genuinely fit testosterone deficiency?
• Are there reversible causes that should be treated first?
• What monitoring will I need and how often?
• Which risks matter most in my personal medical history?

Full-text source: Open the full scientific article

Part II - Women: Regulated Body-Identical Menopause Hormone Therapy

For women, hormone therapy is most often discussed around perimenopause and menopause. Symptoms can include hot flushes, night sweats, sleep disruption, mood changes, anxiety, brain fog, joint aches, vaginal dryness, urinary symptoms, reduced libido and changes in body composition. For some women, these symptoms are mild. For others, they seriously affect work, relationships, confidence and quality of life.

Modern menopause care is not simply about “taking hormones” or “avoiding hormones”. It is about matching the right treatment to the right woman, at the right time, using the right dose and route, with appropriate review.

What “regulated body-identical” means

In this guide, regulated body-identical hormone therapy means licensed medicines such as 17-beta estradiol and micronised progesterone, used where clinically appropriate. These hormones are described as body-identical because their molecular structure matches hormones naturally produced by the body. This does not mean they are risk-free, and it does not mean every woman should use them.

This is different from many compounded “bioidentical” hormone products, which may be individually mixed outside standard licensing systems. Compounded products can raise concerns about dose consistency, quality control, monitoring and evidence.

What a responsible menopause hormone assessment usually considers

• Age, stage of menopause, and time since last menstrual period.
• Main symptoms and how much they affect quality of life.
• Whether the woman has a uterus, because estrogen without adequate endometrial protection can be unsafe for the womb lining.
• Breast history, family history, clotting history, migraine, blood pressure, cardiovascular risk and cancer history.
• Whether local vaginal treatment, systemic treatment, non-hormonal treatment or a combined approach is most appropriate.
• Personal preferences about route, dose, convenience, bleeding patterns, cost and follow-up.

Patient-Friendly Evidence Entries: Women and Hormone Therapy

1. Hormone Replacement Therapy and Cardiovascular Risk in Women

Why this matters for you

This article helps patients understand why age, timing, route and personal cardiovascular risk matter in menopause hormone therapy.

What the research suggests in patient language

• For many women, hormone therapy is most often considered for troublesome menopausal symptoms such as hot flushes, night sweats, sleep disruption and quality-of-life impairment.
• Heart and blood-vessel risk is not the same for every woman; it depends on age, time since menopause, blood pressure, cholesterol, smoking, diabetes, weight and clotting history.
• Transdermal estradiol may be considered in some women where clot or metabolic risk is a concern, but this must be individualised.

What this does not mean

MHT should not be described as a universal heart-protection treatment. It is a symptom and health-management decision based on risk profile.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

2. The Impact of Hormone Replacement Therapy on Cardiovascular and Oncologic Risks: A Systematic Review and Evidence-Based Recommendations

Why this matters for you

This review is useful because many patients worry about both heart disease and cancer when considering hormone therapy.

What the research suggests in patient language

• The evidence suggests that risks and benefits depend strongly on the individual woman and the type of hormone therapy used.
• The term body-identical is best reserved for licensed 17-beta estradiol and micronised progesterone, where clinically appropriate.
• Risk assessment should include breast history, womb status, clot history, family history, migraine, blood pressure, metabolic health and personal preferences.

What this does not mean

No single article can tell every woman what to do. The safest decision comes from personal assessment, not generic reassurance or generic fear.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

3. Relationship Between Menopausal Hormone Therapy and Breast Cancer Risk

Why this matters for you

This article addresses one of the most common patient concerns: breast cancer risk.

What the research suggests in patient language

• Breast cancer risk varies by hormone type, duration of use, age, background risk and whether progesterone/progestogen is needed.
• Women with a uterus usually need endometrial protection alongside estrogen to reduce the risk of womb-lining overgrowth.
• Breast screening, symptom awareness and regular review remain important during treatment.

What this does not mean

A lower-risk formulation does not mean zero risk. Your baseline risk and family history must be discussed.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

4. Hormone Therapy After Oophorectomy and Breast Cancer Risk

Why this matters for you

This article is relevant for women who have had their ovaries removed, especially before the natural age of menopause.

What the research suggests in patient language

• Surgical menopause can cause sudden symptoms and earlier loss of estrogen exposure.
• In some women, hormone therapy may be considered to manage symptoms and reduce consequences of early estrogen loss.
• The risk-benefit balance is different for early surgical menopause than for starting therapy much later after natural menopause.

What this does not mean

A history of oophorectomy does not automatically mean one treatment choice. Personal cancer risk, age, womb status and symptoms matter.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

5. Menopausal Hormone Therapy and Long-Term Mortality

Why this matters for you

This article looks beyond immediate symptom relief and considers longer-term outcomes.

What the research suggests in patient language

• Women often ask whether MHT affects long-term health, not just hot flushes.
• Long-term outcomes depend on timing, formulation, route, age, health background and duration of use.
• Regular reviews help ensure treatment remains aligned with changing health status and patient goals.

What this does not mean

Long-term population data should not be reduced to a simple promise that treatment makes you live longer or a warning that it is always dangerous.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

6. What Systemic Hormone Therapy Black Box Removal Means for Clinical Practice

Why this matters for you

This article is useful for explaining why patient information around MHT has changed over time.

What the research suggests in patient language

• Past warnings sometimes led to broad fear of hormone therapy, even though risk differs by patient and formulation.
• Modern practice is more individualised, with attention to route, dose, timing and the reason for treatment.
• A careful clinician should explain both benefits and risks in plain language.

What this does not mean

Changes in labelling or warnings should not be interpreted as hormone therapy being risk-free. Informed consent remains essential.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

7. The 2025 Menopausal Hormone Therapy Guidelines

Why this matters for you

Guidelines are important because they translate the evidence into practical patient care.

What the research suggests in patient language

• MHT is commonly used for vasomotor symptoms such as hot flushes and night sweats, and may also help sleep and quality of life when symptoms are hormone-related.
• Treatment should be individualised by age, time since menopause, symptom severity, womb status and risk factors.
• Patients should expect periodic review rather than indefinite automatic continuation without reassessment.

What this does not mean

Guidelines support shared decision-making; they do not replace a personalised consultation.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

8. Cardiovascular Risk Associated with Menopause and Menopausal Hormone Therapy

Why this matters for you

This article helps explain why menopause itself changes cardiovascular risk.

What the research suggests in patient language

• After menopause, changes in lipids, blood vessels, insulin resistance and body fat distribution can affect cardiovascular risk.
• Hormone therapy decisions should be made alongside cardiovascular prevention, not separately from it.
• Blood pressure, cholesterol, glucose, weight, exercise, smoking and family history all matter.

What this does not mean

MHT should not be used as a substitute for cardiovascular prevention. Lifestyle and standard medical risk management remain important.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

9. Estradiol and Micronized Progesterone: A Narrative Review of Their Comparative Role in Menopausal Hormone Therapy

Why this matters for you

This article is central for patients interested in regulated body-identical hormone therapy.

What the research suggests in patient language

• Licensed 17-beta estradiol is structurally identical to the main estrogen produced by the ovaries before menopause.
• Micronised progesterone is often described as body-identical progesterone and may be used for womb protection in women who need it.
• This is different from unregulated compounded bioidentical hormone mixtures, which may lack standardised dosing and safety oversight.

What this does not mean

Body-identical does not mean risk-free or suitable for everyone. It means the molecule resembles human hormones and should still be prescribed and monitored medically.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

10. Menopausal Hormone Therapy for Breast Cancer Patients

Why this matters for you

This paper is relevant for women with a personal breast cancer history or those worried about breast cancer risk.

What the research suggests in patient language

• Women with previous breast cancer need specialist advice before considering systemic hormone therapy.
• Non-hormonal options may be preferred or required depending on cancer type, receptor status and current treatment.
• The paper also helps separate regulated body-identical therapy from compounded products.

What this does not mean

Patients with breast cancer history should not self-start hormone therapy. Oncology or specialist menopause input may be necessary.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

11. Menopausal Hormone Therapy - Risks, Benefits and Emerging Options

Why this matters for you

This article gives a balanced overview of why some women benefit from MHT and why some should avoid it.

What the research suggests in patient language

• Common benefits can include improvement in hot flushes, night sweats, sleep disruption, vaginal/urogenital symptoms and quality of life.
• Potential risks may include bleeding problems, breast risk, clot risk, stroke risk or gallbladder issues depending on patient and treatment type.
• Newer options and non-hormonal approaches may be useful for women who cannot or do not want to use systemic hormones.

What this does not mean

Treatment should be based on your symptoms, goals, risk profile and preferences rather than a one-size-fits-all approach.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

12. Reconsidering Hormone Replacement Therapy

Why this matters for you

This article reflects the broader modern reassessment of hormone therapy after years of oversimplified messaging.

What the research suggests in patient language

• Hormone therapy was once commonly discussed in very broad terms, but modern care is more precise.
• The same treatment may be reasonable for one woman and unsuitable for another depending on age, timing and risk factors.
• Patients deserve balanced information rather than fear-based or marketing-based messages.

What this does not mean

Reconsidering MHT does not mean returning to careless prescribing. It means making better individual decisions.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

13. Review of Hormonal Replacement Therapy Options for Menopausal Symptoms and Quality of Life

Why this matters for you

This article is useful for patients comparing practical treatment options.

What the research suggests in patient language

• Options may include tablets, patches, gels, sprays, vaginal estrogen, progesterone/progestogen options and non-hormonal medicines.
• Route matters: some women prefer patches or gels; others prefer oral treatment; some need local vaginal treatment rather than systemic therapy.
• The best option depends on symptoms, medical history, womb status, preferences and cost/access.

What this does not mean

There is no single best hormone treatment for everyone. The safest option is the one that fits your medical profile and is reviewed properly.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

14. European Code Against Cancer, 5th Edition - Hormone-Related Medicines and Cancer

Why this matters for you

This article is included because patients often want honest discussion of cancer-related risks.

What the research suggests in patient language

• Hormone-related medicines can influence cancer risk differently depending on medicine type, duration and patient background.
• Good care involves discussing benefits and risks without either minimising or exaggerating them.
• Cancer screening and symptom awareness remain important parts of women’s health care.

What this does not mean

A cancer-risk discussion should be personalised. General population guidance is not the same as your individual risk profile.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

15. Impact of Menopause Hormone Therapy, Exercise, and Their Combination on Bone Mineral Density

Why this matters for you

This article is helpful for understanding bone health around menopause.

What the research suggests in patient language

• Estrogen loss after menopause can accelerate bone loss in some women.
• MHT can support bone density in appropriate patients, while exercise, protein, vitamin D, calcium intake and fall prevention remain important.
• Bone-health decisions should consider fracture risk, family history, previous fractures, steroid use, smoking and body weight.

What this does not mean

MHT is not the only bone-health treatment and should not replace osteoporosis assessment where needed.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

16. Changes in Sleep Quality After Hormone Replacement Therapy With Micronized Progesterone in Japanese Menopausal Women

Why this matters for you

This article is relevant because sleep disturbance is one of the most frustrating menopause symptoms.

What the research suggests in patient language

• Night sweats can fragment sleep, but some women also experience sleep problems not fully explained by hot flushes.
• Micronised progesterone may have sleep-related benefits for some women, especially when used as part of an appropriate regimen.
• Sleep should still be assessed broadly, including stress, alcohol, caffeine, sleep apnoea, restless legs, medications and mood.

What this does not mean

Hormone therapy may improve sleep when symptoms are hormone-related, but it is not a cure for every sleep disorder.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

17. Compounded Hormonal Pellets: A Critical Review of Current Evidence and Risks

Why this matters for you

This article is important because compounded hormone pellets are often marketed as natural, personalised or bioidentical.

What the research suggests in patient language

• Compounded preparations may not have the same regulatory oversight, dose consistency or safety evidence as licensed medicines.
• Pellets can be difficult to adjust once inserted, which matters if side effects or excessive hormone levels occur.
• Patients should ask whether a product is licensed, what dose is being used, and how levels and side effects will be monitored.

What this does not mean

Natural-sounding marketing does not guarantee safer treatment. Regulated, licensed therapy is generally easier to standardise and monitor.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

18. Subcutaneous Estradiol Pellets as Hormone Therapy in Menopause: Clinical Pharmacology, Patient Selection and Safety Considerations

Why this matters for you

This article discusses estradiol pellets and the importance of careful patient selection.

What the research suggests in patient language

• Pellet therapy may produce long-lasting hormone exposure, but dose adjustment is less flexible than gels, patches or tablets.
• Patient selection, hormone levels, side effects, bleeding patterns and endometrial protection remain important.
• For many patients, licensed transdermal or oral options may be simpler to start, adjust and stop.

What this does not mean

Pellets should not be chosen just because they sound convenient. Flexibility and safety monitoring are part of treatment quality.

Questions to discuss with your clinician

• Which symptoms are we trying to treat and how will we measure improvement?
• Which treatment route and dose best fits my risk profile?
• Do I need progesterone or endometrial protection?
• What warning symptoms or side effects should I report?

Full-text source: Open the full scientific article

Questions to Bring to Your Consultation

A good hormone consultation should feel thorough rather than rushed. The aim is not just to decide whether treatment is possible, but to understand whether it is appropriate, safe and likely to address your goals.

For men considering TRT

• Do I have confirmed testosterone deficiency or only symptoms that could have other causes?
• What are my total testosterone, free testosterone, SHBG, LH, FSH and prolactin results?
• Could sleep apnoea, obesity, medication, stress, alcohol or thyroid disease explain my symptoms?
• What could happen to fertility and sperm production?
• How will haematocrit, PSA, blood pressure, lipids and symptom response be monitored?
• What is the plan if testosterone rises too high or side effects occur?

For women considering regulated body-identical hormone therapy

• Am I perimenopausal, menopausal, surgically menopausal or experiencing symptoms from another cause?
• Is systemic hormone therapy needed, or would local vaginal estrogen or non-hormonal treatment be better?
• Do I need progesterone because I have a uterus?
• Which route is safest for me: patch, gel, spray, tablet, vaginal preparation or another option?
• How do my breast, clot, migraine, blood pressure, cardiovascular and family history risks affect my choices?
• How often should treatment be reviewed, and what symptoms should prompt earlier review?

Hormonal symptoms rarely come from one single number on a blood test. Low energy, weight gain, poor sleep, reduced libido, brain fog, mood changes, poor recovery, cravings and loss of vitality often develop because several body systems are no longer working together as efficiently as they should.

At Hormonal Harmony, we believe that effective hormone care starts with understanding the whole picture. This is why we offer Metabolic Code® as an advanced diagnostic service for patients who want a more complete, personalised and clinically meaningful assessment of their hormonal and metabolic health.

Metabolic Code® is designed to help identify the deeper patterns behind your symptoms. Instead of looking at isolated blood markers in a basic way, it brings together your symptoms, medical history, laboratory results and key metabolic indicators to create a clearer picture of how your body is functioning as an interconnected system.

Many people know that something is not right long before a standard test result appears “abnormal”. They may feel tired, inflamed, foggy, unable to lose weight, emotionally flat, sexually less responsive or generally unlike themselves — yet they are often told that their blood results are “within range”.

The problem is that “within range” does not always mean optimal.

Metabolic Code® helps us look beyond the minimum standard of disease detection. It allows your clinician to assess how your hormones, metabolism, stress response, blood sugar regulation, inflammation, cardiovascular markers, detoxification pathways and sex hormone balance may be interacting with each other.

This is especially valuable in hormone medicine because hormones do not work in isolation. Testosterone, oestrogen, progesterone, thyroid hormones, cortisol, insulin and metabolic markers all influence one another. A patient may appear to have a testosterone problem, for example, while also having insulin resistance, thyroid imbalance, inflammation, high stress load, poor recovery or nutrient issues that affect the final treatment outcome.

Metabolic Code® helps reveal these relationships more clearly.

The Metabolic Code® system organises your health information into five key functional areas, often called Triads. Each Triad represents a group of body systems that work closely together.

Together, these five areas create a more complete map of your body’s current functional state.

A better foundation for your treatment plan

Hormone therapy should never be guesswork. The aim is not simply to prescribe testosterone, oestrogen, progesterone or another treatment as quickly as possible. The aim is to understand what your body needs, what may be driving your symptoms, and how treatment can be designed safely and intelligently.

Metabolic Code® gives your clinician a stronger foundation for that decision-making process. It can help identify whether your symptoms are mainly hormonal, metabolic, inflammatory, stress-related, nutritional, thyroid-related, blood-sugar-related or a combination of several factors.

This matters because the best treatment plan for one patient may be very different from the best treatment plan for another.

For some patients, hormone therapy may be appropriate. For others, the priority may be improving metabolic health first. Some patients may benefit from targeted lifestyle changes, nutritional support, weight management, sleep improvement, stress regulation, thyroid assessment, insulin control or a more detailed medical review before hormone treatment is started.

Metabolic Code® helps make that pathway clearer.

Who should consider Metabolic Code®?

Metabolic Code® may be especially valuable if you:

Feel tired despite sleeping enough
Struggle with weight gain or fat loss
Have low libido or reduced sexual function
Experience brain fog, low mood or poor concentration
Feel that your body has changed with age
Are considering testosterone replacement therapy
Are experiencing perimenopause or menopause symptoms
Have poor recovery after exercise
Feel stressed, inflamed or hormonally “out of balance”
Have been told your results are “normal” but still feel unwell
Want a more complete understanding before starting treatment
Want a personalised plan rather than a generic approach

It is also ideal for patients who want to be proactive. You do not need to wait until your health has seriously declined before taking action. Metabolic Code® can help detect patterns that may be affecting energy, vitality and long-term wellbeing before they become more difficult to correct.

How it works at Hormonal Harmony

Your journey begins with an initial online consultation, where we review your symptoms, health goals and medical background. If appropriate, we then arrange the relevant blood tests and diagnostic investigations.

Metabolic Code® can then be added as an advanced assessment layer. Your results are interpreted in the context of your symptoms, your lifestyle, your hormone profile and your wider metabolic health.

Your clinician will then use this information to help build a personalised plan. This may include hormone therapy where clinically appropriate, but it may also include recommendations around nutrition, weight management, sleep, stress, exercise, supplements, metabolic support or further investigation.

The goal is simple: to give you a treatment plan that is safer, more precise and more relevant to the way your body actually works.

Why choose Metabolic Code® with Hormonal Harmony?

At Hormonal Harmony, your care is led by medical expertise, not by a one-size-fits-all protocol. Dr Ferenc Kovari and the clinical team take a careful, medically responsible approach to hormone optimisation, TRT, bioidentical hormone replacement and metabolic health.

Metabolic Code® supports this approach by giving both you and your clinician a more detailed understanding of what is happening beneath the surface.

It helps us answer better questions:

Why are you tired?
Why are you gaining weight?
Why is your libido low?
Why is your recovery poor?
Why do your symptoms persist despite “normal” results?
What needs to be corrected first?
Is hormone therapy appropriate?
How can your treatment be made safer, more targeted and more effective?

This is the difference between basic testing and intelligent, personalised hormone care.

Take the next step

If you want the most complete understanding of your hormonal and metabolic health, Metabolic Code® is the ideal next step.

It gives you deeper insight, a clearer direction and a more personalised treatment pathway. Instead of guessing what your body needs, you can make informed decisions with expert medical guidance.

Book your Hormonal Harmony consultation today and ask about adding Metabolic Code® to your assessment. The more clearly we understand your body, the more precisely we can help you restore balance, vitality and long-term wellbeing.